FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296360841> ?p ?o ?g. }

• W4296360841 abstract "Current drug screening protocols use in vitro cancer cell panels grown in 2D to evaluate drug response and select the most promising candidates for further in vivo testing. Most drug candidates fail at this stage, not showing the same efficacy in vivo as seen in vitro. An improved first screening that is more translatable to the in vivo tumor situation could aid in reducing both time and cost of cancer drug development. 3D cell cultures are an emerging standard for in vitro cancer cell models, being more representative of in vivo tumour conditions. To overcome the translational challenges with 2D cell cultures, 3D systems better model the more complex cell-to-cell contact and nutrient levels present in a tumour, improving our understanding of cancer complexity. Furthermore, cancer cells exhibit altered metabolism, a phenomenon described a century ago by Otto Warburg, and possibly related to changes in nutrient access. However, there are few reports on how 3D cultures differ metabolically from 2D cultures, especially when grown in physiological glucose conditions. Along with this, metabolic drug targeting is considered an underutilized and poorly understood area of cancer therapy. Therefore, the aim of this work was to investigate the effect of culture conditions on response to metabolic drugs and study the metabolism of 3D spheroid cultures in detail. To achieve this, multiple cancer cell lines were studied in high and low glucose concentrations and in 2D and 3D cultures. We found that glucose concentration is important at a basic level for growth properties of cell lines with different metabolic phenotypes and it affects sensitivity to metformin. Furthermore, metformin is able to shift metabolic phenotype away from OXPHOS dependency. There are significant differences in glucose metabolism of 3D cultures compared to 2D cultures, both related to glycolysis and oxidative phosphorylation. Spheroids have higher ATP-linked respiration in standard nutrient conditions and higher non-aerobic ATP production in the absence of supplemented glucose. Multi-round treatment of spheroids is able to show more robust response than standard 2D drug screening, including resistance to therapy. Results from 2D cultures both over and underestimate drug response at different concentrations of 5-fluorouracil (5-FU). A higher maximum effect of 5-FU is seen in models with lower OCR/ECAR ratios, an indication of a more glycolytic metabolic phenotype. In conclusion, both culture method and nutrient conditions are important consideration for in vitro cancer models. There is good reason to not maintain in vitro cultures in artificially high glucose conditions. It can have downstream affects on drug response and likely other important metrics. If possible, assays should also be implemented in 3D. If not in everyday assays, at least as a required increase in complexity to validate 2D results. Finally, metabolism even in the small scope presented here, is complex in terms of phenotypic variation. This shows the importance of metabolic screening in vitro to better understand the effects of these small changes and to model how a specific tumor may behave based on its complex metabolism." @default.
• W4296360841 created "2022-09-20" @default.
• W4296360841 creator A5090440621 @default.
• W4296360841 date "2021-01-01" @default.
• W4296360841 modified "2023-09-28" @default.
• W4296360841 title "3D in vitro cancer models for drug screening: A study of glucose metabolism and drug response in 2D and 3D culture models" @default.
• W4296360841 cites W1507410482 @default.
• W4296360841 cites W1522450221 @default.
• W4296360841 cites W1608926155 @default.
• W4296360841 cites W1793329854 @default.
• W4296360841 cites W1932416745 @default.
• W4296360841 cites W1964126982 @default.
• W4296360841 cites W1970168377 @default.
• W4296360841 cites W1976516202 @default.
• W4296360841 cites W1980080300 @default.
• W4296360841 cites W1980568044 @default.
• W4296360841 cites W1980843797 @default.
• W4296360841 cites W1997303839 @default.
• W4296360841 cites W1997596656 @default.
• W4296360841 cites W2002583208 @default.
• W4296360841 cites W2012939994 @default.
• W4296360841 cites W2013735638 @default.
• W4296360841 cites W2019789647 @default.
• W4296360841 cites W2026967508 @default.
• W4296360841 cites W2028279608 @default.
• W4296360841 cites W2033733148 @default.
• W4296360841 cites W2034176597 @default.
• W4296360841 cites W2034269086 @default.
• W4296360841 cites W2040789365 @default.
• W4296360841 cites W2045387133 @default.
• W4296360841 cites W2047209914 @default.
• W4296360841 cites W2048981098 @default.
• W4296360841 cites W2050253364 @default.
• W4296360841 cites W2052700237 @default.
• W4296360841 cites W2057280155 @default.
• W4296360841 cites W2062581381 @default.
• W4296360841 cites W2063048290 @default.
• W4296360841 cites W2072451938 @default.
• W4296360841 cites W2081381416 @default.
• W4296360841 cites W2083258699 @default.
• W4296360841 cites W2087886451 @default.
• W4296360841 cites W2095987251 @default.
• W4296360841 cites W2103209526 @default.
• W4296360841 cites W2104696999 @default.
• W4296360841 cites W2111152401 @default.
• W4296360841 cites W2115124692 @default.
• W4296360841 cites W2117692326 @default.
• W4296360841 cites W2118107482 @default.
• W4296360841 cites W2119698183 @default.
• W4296360841 cites W2120373734 @default.
• W4296360841 cites W2123059506 @default.
• W4296360841 cites W2128578138 @default.
• W4296360841 cites W2134650984 @default.
• W4296360841 cites W2150794045 @default.
• W4296360841 cites W2157655280 @default.
• W4296360841 cites W2159494912 @default.
• W4296360841 cites W2160425601 @default.
• W4296360841 cites W2161372685 @default.
• W4296360841 cites W2166550586 @default.
• W4296360841 cites W2171524987 @default.
• W4296360841 cites W2172829973 @default.
• W4296360841 cites W2183106106 @default.
• W4296360841 cites W2234115940 @default.
• W4296360841 cites W2258066491 @default.
• W4296360841 cites W2267520918 @default.
• W4296360841 cites W2278029862 @default.
• W4296360841 cites W2294314809 @default.
• W4296360841 cites W2295718866 @default.
• W4296360841 cites W2297957816 @default.
• W4296360841 cites W2312291090 @default.
• W4296360841 cites W2331141044 @default.
• W4296360841 cites W2331628193 @default.
• W4296360841 cites W2345381093 @default.
• W4296360841 cites W2406803433 @default.
• W4296360841 cites W2413682132 @default.
• W4296360841 cites W2460593466 @default.
• W4296360841 cites W2500510969 @default.
• W4296360841 cites W2519338564 @default.
• W4296360841 cites W2551375131 @default.
• W4296360841 cites W2558846435 @default.
• W4296360841 cites W2563494429 @default.
• W4296360841 cites W2575829193 @default.
• W4296360841 cites W2586921436 @default.
• W4296360841 cites W2587770349 @default.
• W4296360841 cites W2592588133 @default.
• W4296360841 cites W2593338845 @default.
• W4296360841 cites W2594036641 @default.
• W4296360841 cites W2597387377 @default.
• W4296360841 cites W2604353006 @default.
• W4296360841 cites W2611436342 @default.
• W4296360841 cites W2613674801 @default.
• W4296360841 cites W2616142271 @default.
• W4296360841 cites W2751844374 @default.
• W4296360841 cites W2751844984 @default.
• W4296360841 cites W2758067903 @default.
• W4296360841 cites W2763979809 @default.
• W4296360841 cites W2767576903 @default.
• W4296360841 cites W277256728 @default.
• W4296360841 cites W2782270876 @default.
• W4296360841 cites W2783495684 @default.

• next